330 likes | 339 Views
Application of Biosimilars in RA IN Clinical Practice: Key Issues and Challenges. Introduction. Differences Between Generics and Biosimilars. Clinical Development Program: Biosimilars. Differences Between Development of New Generics and New Biosimilar Medications.
E N D
Application of Biosimilars in RA IN Clinical Practice:Key Issues and Challenges
Differences Between Development of New Generics and New Biosimilar Medications
Clinical Study of Rituximab Biosimilar Candidate CT-P10 Performed in RA
Starting a Patient on a Biosimilar: Another Clinician’s Perspective
DANBIO Registry: Effect of Nonmedical Switch From Originator to Biosimilar Infliximab
Adherence Results for the DANBIO Registry After a Nonmedical Switch